BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
BCTX on Nasdaq
Shares outstanding
4,043,321
Price per share
$0.73
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
66
Total reported value
$48
Share change
-61,700
Value change
-$180,863
Number of holders
1
Price from insider filings
$0.73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Iroquois Capital Management, LLC 9.1% $5,072,000 1,600,000 Richard Abbe 15 Jul 2025
CVI Investments, Inc. 5.7% +16% $3,170,000 +$2,041,841 1,000,000 +181% CVI Investments, Inc. 15 Jul 2025
ARMISTICE CAPITAL, LLC 8.3% $231,840 336,000 Armistice Capital, LLC 30 Jun 2025
3i, LP 4.9% -50% $836,026 -$787,574 190,006 -49% 3i, LP 31 Mar 2025

As of 30 Sep 2025, 1 institutional investors reported holding 66 shares of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX). This represents 0% of the company’s total 4,043,321 outstanding shares.

Institutional Holders of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 66 $48 -$180,863 $0.73 1
2025 Q2 61,766 $181,057 +$105,526 $2.94 15
2025 Q1 25,827 $94,139 +$94,139 $3.65 13